Beverly Hills Biotech Claims Two Day Cure For Alcoholism
CITA Biomedical, Inc, which specialises in developing drugs to treat alchohol and substance addiction, today reported that a patient had been successfully treated for alcohol dependence in the space of two days. Detoxification and Neubeen roAdaptation, is a part of a family of treatments called, rather confusingly, DNA.
The patient, a 62-year-old male who had been dependant on alcohol for over 40 years was treated with DNA for Alcohol. The patient was consuming an average of 1.5 litres of gin, brandy, and beer a day. The treatment was administered to the patient over two consecutive days where the patient experienced no symptoms of withdrawal. After treatment the patient said he felt an overwhelming sense of happiness, had no cravings for alcohol, and mental clarity that he had not felt for years.
DNA for Alcohol establishes a new treatment regimen in the fight against alcoholism, a disorder that impedes normal neural functioning of the brain and body systems as a whole. Alcoholism causes cravings, possible brain damage, and can lead to potentially life-threatening withdrawal symptoms. It appears that the CITA DNA treatment provides a solution for treating both the physiological and psychological components of the condition.
Patients were also treated in Europe last year and less than 25 per cent relapsed back into drinking, compared to the more than 75 percent relapse rate generally associated other accepted means of treatment. The new treatment was also shown to reduce the time, pain, and costs associated with withdrawal, and allowed the patients to return to a productive level of functioning within hours of the treatment's completion.
"We feel DNA for Addictions will revolutionise the treatment of substance dependence worldwide," said Joseph Dunn, president and CEO of CITA Biomedical. "We anticipate that this patient will be the first of thousands that we will treat for alcohol dependence in the coming year. Our mission is to make the transition from substance dependence to independence as smooth and humane as possible and with DNA for Addictions we've done that."
The DNA for Addictions treatment family includes DNA for Alcohol, DNA for Alcohol and Cocaine, DNA for Cocaine, and DNA for Crack Cocaine. CITA has patents pending for the family of DNA treatments.
The company holds the U.S. patent for its successful UROD (Ultra Rapid Opiate Detoxification), the only clinically tested and effective treatment method to rapidly detoxify individuals addicted to opiate-based drugs, including heroin, within four to six hours with few, if any, withdrawal symptoms. CITA now seeks complementing technologies and acquisitions to enhance its product portfolio.
www.citabio.com/
Delicious
Digg
Reddit
Magnoliacom
Newsvine
Furl
Google
Yahoo
Technorati
Comments
Post new comment